APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medical Radioisotopes

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Radioisotopes Market Outlook and Growth Opportunities 2026

Report ID 173894740421 December 2025193 pages

Choose your research edition.

Industry ResearchMedical Radioisotopes Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Radioisotopes Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Medical Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Radioisotopes Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Radioisotopes Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Medical Radioisotopes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Radioisotopes market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Radioisotopes market include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Radioisotopes market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Radioisotopes and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Radioisotopes revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Radioisotopes market.

Medical Radioisotopes Segment by Company

NRG

IRE

ANSTO

NTP Radioisotopes

China National Nuclear Corporation

Rosatom

Nordion

Eckert & Ziegler Strahlen

Polatom

Medical Radioisotopes Segment by Type

Tc-99m

Cobalt-60

Iodine Radioisotopes

Medical Radioisotopes Segment by Application

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Others

Medical Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Radioisotopes status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Radioisotopes key companies, revenue, market share, and recent developments.

3. To split the Medical Radioisotopes breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Radioisotopes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Radioisotopes significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Radioisotopes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Radioisotopes industry.

Chapter 3: Detailed analysis of Medical Radioisotopes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Radioisotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Radioisotopes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Radioisotopes Industry Trends Table 2. Medical Radioisotopes Industry Drivers Table 3. Medical Radioisotopes Industry Opportunities and Challenges Table 4. Medical Radioisotopes Industry Restraints Table 5. Global Medical Radioisotopes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Radioisotopes Revenue Share by Company (2021-2026) Table 7. Global Medical Radioisotopes Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Radioisotopes Key Company Manufacturing Base & Headquarters Table 9. Global Medical Radioisotopes Company, Product Type & Application Table 10. Global Medical Radioisotopes Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tc-99m Table 15. Significant Companies of Cobalt-60 Table 16. Significant Companies of Iodine Radioisotopes Table 17. Global Medical Radioisotopes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Medical Radioisotopes Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Medical Radioisotopes Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Medical Radioisotopes Sales Value Share by Type (2021-2026) Table 21. Global Medical Radioisotopes Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Nuclear Therapy Table 23. Significant Companies of Equipment Radioactive Source Table 24. Significant Companies of Diagnosis Table 25. Significant Companies of Others Table 26. Global Medical Radioisotopes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Radioisotopes Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Medical Radioisotopes Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Medical Radioisotopes Sales Value Share by Application (2021-2026) Table 30. Global Medical Radioisotopes Sales Value Share by Application (2027-2032) Table 31. Global Medical Radioisotopes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical Radioisotopes Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Medical Radioisotopes Sales Value Share by Region (2021-2026) Table 34. Global Medical Radioisotopes Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Medical Radioisotopes Sales Value Share by Region (2027-2032) Table 36. Global Medical Radioisotopes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Medical Radioisotopes Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Medical Radioisotopes Sales Value Market Share by Country (2021-2026) Table 39. Global Medical Radioisotopes Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Medical Radioisotopes Sales Value Market Share by Country (2027-2032) Table 41. NRG Company Information Table 42. NRG Business Overview Table 43. NRG Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. NRG Medical Radioisotopes Product Portfolio Table 45. NRG Recent Development Table 46. IRE Company Information Table 47. IRE Business Overview Table 48. IRE Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. IRE Medical Radioisotopes Product Portfolio Table 50. IRE Recent Development Table 51. ANSTO Company Information Table 52. ANSTO Business Overview Table 53. ANSTO Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. ANSTO Medical Radioisotopes Product Portfolio Table 55. ANSTO Recent Development Table 56. NTP Radioisotopes Company Information Table 57. NTP Radioisotopes Business Overview Table 58. NTP Radioisotopes Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. NTP Radioisotopes Medical Radioisotopes Product Portfolio Table 60. NTP Radioisotopes Recent Development Table 61. China National Nuclear Corporation Company Information Table 62. China National Nuclear Corporation Business Overview Table 63. China National Nuclear Corporation Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. China National Nuclear Corporation Medical Radioisotopes Product Portfolio Table 65. China National Nuclear Corporation Recent Development Table 66. Rosatom Company Information Table 67. Rosatom Business Overview Table 68. Rosatom Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Rosatom Medical Radioisotopes Product Portfolio Table 70. Rosatom Recent Development Table 71. Nordion Company Information Table 72. Nordion Business Overview Table 73. Nordion Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Nordion Medical Radioisotopes Product Portfolio Table 75. Nordion Recent Development Table 76. Eckert & Ziegler Strahlen Company Information Table 77. Eckert & Ziegler Strahlen Business Overview Table 78. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio Table 80. Eckert & Ziegler Strahlen Recent Development Table 81. Polatom Company Information Table 82. Polatom Business Overview Table 83. Polatom Medical Radioisotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Polatom Medical Radioisotopes Product Portfolio Table 85. Polatom Recent Development Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Medical Radioisotopes Product Image Figure 2. Global Medical Radioisotopes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Radioisotopes Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tc-99m Image Figure 8. Cobalt-60 Image Figure 9. Iodine Radioisotopes Image Figure 10. Global Medical Radioisotopes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Medical Radioisotopes Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Medical Radioisotopes Sales Value Share by Type (2021-2032) Figure 13. Nuclear Therapy Image Figure 14. Equipment Radioactive Source Image Figure 15. Diagnosis Image Figure 16. Others Image Figure 17. Global Medical Radioisotopes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Medical Radioisotopes Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Medical Radioisotopes Sales Value Share by Application (2021-2032) Figure 20. Global Medical Radioisotopes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Medical Radioisotopes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Medical Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 23. North America Medical Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Medical Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Medical Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Medical Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Medical Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Medical Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 29. South America Medical Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Medical Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Medical Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Medical Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • Cobalt-60
  • Iodine Radioisotopes
Applications
  • Nuclear Therapy
  • Equipment Radioactive Source
  • Diagnosis
  • Others
Companies covered
  • NRG
  • IRE
  • ANSTO
  • NTP Radioisotopes
  • China National Nuclear Corporation
  • Rosatom
  • Nordion
  • Eckert & Ziegler Strahlen
  • Polatom

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Radioisotopes Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Radioisotopes Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Radioisotopes Market Dynamics
  1. 2.1 Medical Radioisotopes Industry Trends
  2. 2.2 Medical Radioisotopes Industry Drivers
  3. 2.3 Medical Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Medical Radioisotopes Industry Restraints
3 Medical Radioisotopes Market by Company
  1. 3.1 Global Medical Radioisotopes Company Revenue Ranking in 2025
  2. 3.2 Global Medical Radioisotopes Revenue by Company (2021-2026)
  3. 3.3 Global Medical Radioisotopes Company Ranking (2024-2026)
  4. 3.4 Global Medical Radioisotopes Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Radioisotopes Company Product Type and Application
  6. 3.6 Global Medical Radioisotopes Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Radioisotopes Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Radioisotopes Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Radioisotopes Market by Type
  1. 4.1 Medical Radioisotopes Type Introduction
  2. 4.1.1 Tc-99m
  3. 4.1.2 Cobalt-60
  4. 4.1.3 Iodine Radioisotopes
  5. 4.2 Global Medical Radioisotopes Sales Value by Type
  6. 4.2.1 Global Medical Radioisotopes Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical Radioisotopes Sales Value by Type (2021-2032)
  8. 4.2.3 Global Medical Radioisotopes Sales Value Share by Type (2021-2032)
5 Medical Radioisotopes Market by Application
  1. 5.1 Medical Radioisotopes Application Introduction
  2. 5.1.1 Nuclear Therapy
  3. 5.1.2 Equipment Radioactive Source
  4. 5.1.3 Diagnosis
  5. 5.1.4 Others
  6. 5.2 Global Medical Radioisotopes Sales Value by Application
  7. 5.2.1 Global Medical Radioisotopes Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medical Radioisotopes Sales Value by Application (2021-2032)
  9. 5.2.3 Global Medical Radioisotopes Sales Value Share by Application (2021-2032)
6 Medical Radioisotopes Regional Value Analysis
  1. 6.1 Global Medical Radioisotopes Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Radioisotopes Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Radioisotopes Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Radioisotopes Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Radioisotopes Sales Value (2021-2032)
  7. 6.3.2 North America Medical Radioisotopes Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Radioisotopes Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Radioisotopes Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Radioisotopes Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Radioisotopes Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Radioisotopes Sales Value (2021-2032)
  16. 6.6.2 South America Medical Radioisotopes Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Radioisotopes Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Radioisotopes Sales Value Share by Country, 2025 VS 2032
7 Medical Radioisotopes Country-level Value Analysis
  1. 7.1 Global Medical Radioisotopes Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Radioisotopes Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Radioisotopes Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Radioisotopes Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Radioisotopes Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Radioisotopes Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Radioisotopes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 NRG
  2. 8.1.1 NRG Company Information
  3. 8.1.2 NRG Business Overview
  4. 8.1.3 NRG Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  5. 8.1.4 NRG Medical Radioisotopes Product Portfolio
  6. 8.1.5 NRG Recent Developments
  7. 8.2 IRE
  8. 8.2.1 IRE Company Information
  9. 8.2.2 IRE Business Overview
  10. 8.2.3 IRE Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IRE Medical Radioisotopes Product Portfolio
  12. 8.2.5 IRE Recent Developments
  13. 8.3 ANSTO
  14. 8.3.1 ANSTO Company Information
  15. 8.3.2 ANSTO Business Overview
  16. 8.3.3 ANSTO Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ANSTO Medical Radioisotopes Product Portfolio
  18. 8.3.5 ANSTO Recent Developments
  19. 8.4 NTP Radioisotopes
  20. 8.4.1 NTP Radioisotopes Company Information
  21. 8.4.2 NTP Radioisotopes Business Overview
  22. 8.4.3 NTP Radioisotopes Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NTP Radioisotopes Medical Radioisotopes Product Portfolio
  24. 8.4.5 NTP Radioisotopes Recent Developments
  25. 8.5 China National Nuclear Corporation
  26. 8.5.1 China National Nuclear Corporation Company Information
  27. 8.5.2 China National Nuclear Corporation Business Overview
  28. 8.5.3 China National Nuclear Corporation Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  29. 8.5.4 China National Nuclear Corporation Medical Radioisotopes Product Portfolio
  30. 8.5.5 China National Nuclear Corporation Recent Developments
  31. 8.6 Rosatom
  32. 8.6.1 Rosatom Company Information
  33. 8.6.2 Rosatom Business Overview
  34. 8.6.3 Rosatom Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Rosatom Medical Radioisotopes Product Portfolio
  36. 8.6.5 Rosatom Recent Developments
  37. 8.7 Nordion
  38. 8.7.1 Nordion Company Information
  39. 8.7.2 Nordion Business Overview
  40. 8.7.3 Nordion Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nordion Medical Radioisotopes Product Portfolio
  42. 8.7.5 Nordion Recent Developments
  43. 8.8 Eckert & Ziegler Strahlen
  44. 8.8.1 Eckert & Ziegler Strahlen Company Information
  45. 8.8.2 Eckert & Ziegler Strahlen Business Overview
  46. 8.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio
  48. 8.8.5 Eckert & Ziegler Strahlen Recent Developments
  49. 8.9 Polatom
  50. 8.9.1 Polatom Company Information
  51. 8.9.2 Polatom Business Overview
  52. 8.9.3 Polatom Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Polatom Medical Radioisotopes Product Portfolio
  54. 8.9.5 Polatom Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst